Unigen Pharmaceuticals Presents Scientific Data on Novel Skin Care Ingredient

Lacey, WA – September 15, 2005 – Unigen Pharmaceuticals, Inc., a leading research and development facility and supplier of proprietary, biologically active plant-derived ingredients to the natural products and pharmaceutical industries, made an oral presentation at the 24th International Scientific Seminar sponsored by the International Aloe Science Council (IASC) on South Padre Island, Texas September 9-10.

Dr. Qi Jia, Unigen’s Chief Scientific Officer, presented recent human clinical safety study data for Unigen’s Aloe-originated skincare ingredient, Aloewhite®. Unigen has studied Aloe-derived aromatic compounds since 1995.
“For the past 23 years, the International Aloe Science Council has conducted its annual scientific seminar to bring together Aloe researchers from around the world to convene their scientific exploration on Aloe plants,” said Dr. Jia. “Unigen is grateful for this wonderful opportunity to share valuable information on the research it has carried out on Aloe-based products.” He added, “The IASC places great importance on scientific research and helps publicize the efforts of those scientists who have made outstanding, original research contributions to the science of Aloe, including studies in agriculture, manufacturing, pharmacology, chemistry and biology.”
AloeWhite® is a patented, cosmetic-grade raw material ingredient with potent Oxygen Radical Absorbance Capacity (ORAC). It has demonstrated the ability to repair aged and photo-damaged skin with the effect of modulating skin tone to a youthful appearance. Dr. Jia highlighted the ingredient’s safety profile and benefits as an innovative skin care product in the anti-aging and skin lightening arenas.

Aloe is a top-ten best selling herbal ingredient in the U.S., with records of medicinal usage traced back to 1500 BC in Egypt. Based on a survey conducted by the IASC, during the past 12 months, 1,557 new cosmetic and dietary products contain value-added, efficacious Aloe-based ingredients.

# # #

About Unigen Pharmaceuticals, Inc.
Unigen Pharmaceuticals, Inc. (www.UnigenPharma.com) is a leading natural products research and development company and proprietary ingredients supplier. The company is dedicated to the discovery of botanically derived therapeutic compounds that address consumer health needs and help improve the quality of human life. Its research and discovery process includes extensive work at both the human cell and gene level. Unigen and sister company Aloecorp, Inc. each focus on identifying and studying the unique ingredients of medicinal botanicals (Aloecorp’s focus is on Aloe vera) and then formulating proprietary raw materials for use in cosmeceutical, nutraceutical and pharmaceutical products.

Regan Miles, President & Chief Operating Officer
303-284-4087 360-486-8200 x1511
[email protected]

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.